New meta-analysis data suggest that temporary intragastric devices significantly improve liver morphology and biochemical ...

Metabolic dysfunction-associated steatohepatitis, or MASH, is a disease at the intersection of metabolic and hepatic dysfunction — creating a complex clinical picture for people living with this ...

Hepatic steatosis, often triggered by non-alcoholic fatty liver disease (NAFLD), is a leading cause of liver dysfunction globally, affecting approximately 30% of the population. The progression from ...

AI-driven gamma-ray precision: Effect of convolutional neural networks on chemotherapy side effects. A phase Ib clinical study to evaluate the safety, tolerability, pharmacokinetic profile and ...